Lexicon Pharma Ditches Investor Suit Over Diabetes Drug
A Texas federal judge said Friday that it would be futile for investors who'd already "pleaded their best case" to amend claims that Lexicon Pharmaceuticals overpromised on its ability to bring...To view the full article, register now.
Already a subscriber? Click here to view full article